Navigation Links
Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
Date:5/12/2008

All Patients in Cohort 3 Demonstrated Improvement in T-Cell Responses

Further Supporting the Therapeutic Potential of HspE7

SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced positive immunological data from the third cohort of its ongoing Phase 1 clinical trial of its lead product candidate, HspE7, in patients with cervical intraepithelial neoplasia, or CIN, a precursor to cervical cancer. HPV 16 E7-specific T-cell responses were elicited in all four subjects in the study's third cohort following administration of 500 mcg of HspE7 and 1,000 mcg of Poly-ICLC, a potent toll-like receptor 3 (TLR-3) adjuvant. All T-cell responses represented significant changes from baseline, indicating that the responses were a direct result of treatment with HspE7. As previously announced, three out of four of the patients in cohort 2 (administered 500 mcg of HspE7 and 500 mcg of Poly-ICLC) demonstrated a T-cell response, which may validate that HspE7 is more active with an elevated dose of adjuvant.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080303/LAM023LOGO)

"We continue to be very encouraged with the immunological results from our Phase 1 HspE7 trial as they demonstrate that administration of HspE7 induces T-cell responses that we believe to be therapeutic," said Gregory M. McKee, president and chief executive officer at Nventa. "These positive immunological data, along with the safety data analyzed to date, provide a strong foundation for our Phase 2 trial expected to begin mid-2008."

Independent research findings recently published in the journal Gynecologic Oncology by Jeffrey Weber, M.D., Ph.D., associate director for clinical research at the University of Southern California's Norris Comprehensive Cancer Center, demonstrated that such an immune response may be associated with objective c
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
2. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
3. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
4. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will report ... Ken Berger , CEO, and Ed Borkowski , ... live via telephone. To participate in the conference call ... To participate in the conference call outside the U.S. and ... conference ID is 72195398. Participants should dial in 10 minutes ...
(Date:5/17/2013)... 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ( ... is developing new, patent-pending technologies poised to redefine how consumers ... will hold a business update teleconference and webcast for shareholders ... 2013 at 4:30 PM ET. Fuse Science, ... the call and will be joined by Rubin ...
(Date:5/17/2013)... SEATTLE , May 17, 2013  Atossa Genetics, Inc. ... today that Kyle Guse , Chief Financial ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hyatt Hotel. The Company,s presentation is scheduled ... via a live webcast. To access the webcast, go to ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3
(Date:5/19/2013)... Colorado (PRWEB) May 19, 2013 Farming ... first seed in the ground 10,000 years ago. Most ... increased farm productivity by using genetically engineered seeds and ... now seeing a backlash to these techniques due to ... and chemicals and a corresponding surge in interest in ...
(Date:5/19/2013)... Vegas, Nevada (PRWEB) May 19, 2013 ... agency , is proud to announce the launch it's ... Awards at the MGM Grand on 5/19/2013. Consumers traveling ... all new special pricing available on VegasHotelEscapes.com's website. Travelers ... that they beat any competitors price. , Vegas Hotel ...
(Date:5/19/2013)... Exciting new Skin Brushes are available ... great practice known through the ages but is a ... body brushing, has so many benefits for our health ... "We love that circulation and lymphatic systems get a ... skin, is supported through Skin Brushing." , Why is ...
(Date:5/19/2013)... Aires, Argentina: Yoga classes ( clases de Yoga ) ... the Sivananda Yoga Vedanta Center. The center is ... Classes are 90 minutes and are offered all week ... calm environment, allowing visitors to enjoy the benefits of ... others. , The Yoga classes follow the following principles: ...
(Date:5/19/2013)... Minor fender benders and serious car ... parties to the accident to respond appropriately to the ... Prevention (CDC) data from 2010, accidents, including car accidents, ... In fact, in 2005, automobile accident-related deaths ... than 2.3 million drivers and passengers receive treatment in ...
Breaking Medicine News(10 mins):Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2
... LOS ANGELES (May 30, 2012) Patricia Dickson, M.D., ... at Harbor-UCLA Medical Center (LA BioMed), is co-principal investigator ... million grant from the California Institute for Regenerative Medicine ... develop a stem cell based therapy for the treatment ...
... HealthDay Reporter , TUESDAY, May 29 (HealthDay News) -- ... twice as likely to have a child with autism spectrum ... Exactly how, or even if, fevers may increase the risk ... women should not panic if they do develop a fever ...
... premier event for sleep and circadian science that blends the ... SLEEP 2012, the 26th Annual Meeting of the Associated Professional ... B. Hynes Veterans Memorial Convention Center. SLEEP is filled with ... medicine and sleep research. This year,s program (available at ...
... (HealthDay News) -- ,Adult survivors of childhood cancer can ... of the long-term physical effects of their cancer treatment, ... the Childhood Cancer Survivor Study to assess the effects ... more than 14,000 adult survivors of childhood cancer. The ...
... the Dana-Farber/Children,s Hospital Cancer Center have developed an ... chemotherapy and radiation often encountered in certain blood ... The strategy could pave the way ... and refractory blood cancers, which are difficult to ...
... AURORA, Colo. (May 29, 2012) A Colorado ... designed to illuminate financial links between doctors and pharmaceutical ... physicians prescribe. "If the policymakers who passed these ... be disappointed," said the study,s lead author, Genevieve Pham-Kanter, ...
Cached Medicine News:Health News:LA BioMed's Dr. Patricia Dickson researching treatments for neurodegenerative disorders 2Health News:Fever During Pregnancy May Raise Odds for Autism in Offspring 2Health News:Fever During Pregnancy May Raise Odds for Autism in Offspring 3Health News:SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston 2Health News:Emotional Woes May Last for Childhood Cancer Survivors 2Health News:New drug strategy attacks resistant leukemia and lymphoma 2Health News:New drug strategy attacks resistant leukemia and lymphoma 3Health News:New federal disclosure law may have little impact on drugs prescribed 2
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
Medicine Products: